Home

Psychosis

Read time: 5 min

Congress highlights

Exploring the relationship between cannabis use and psychosis

Epidemiological evidence demonstrates an association between the use of cannabis and increased risk...

Read time: 3 min

Congress highlights

Is highly potent cannabis driving first episode psychosis?

Regular use of potent cannabis is strongly linked to the incidence of psychosis, according to...

Read time: 3 min

Satellite symposium

Small steps for big impact in treatment of schizophrenia

Functional recovery is an important goal in treating schizophrenia, but one that can be hard to...

Read time: 4 min

Congress highlights

Psychosis during the COVID19 pandemic – who’s coping?

The effects of the COVID19 pandemic have impacted everyone to a greater or lesser extent, often...

Read time: 3 min

Congress highlights

Can people with ultra-high risk of psychosis benefit from cognitive remediation?

The FOCUS study failed to show neuro- and social-cognitive benefits of cognitive remediation in...

Digital technology in psychosis – it’s no delusion

The application of digital interventions is starting to emerge as part of a rapidly expanding cache...

Digital technology in psychosis – it’s no delusion

Read time: 3 min

Digital technology in psychosis – it’s no delusion

The application of digital interventions is starting to emerge as part of a rapidly expanding cache...

Read time: 5 min

Congress highlights

Ultra High Risk – fact or fiction?

An EPA 2019 debate presented the data supporting the cases both for and against abandonment of...

Parkinson's Disease

Read time: 3 min

New therapeutic technologies and targets for Parkinson’s disease

A gastroretentive capsule containing multiple layers of biodegradable film, intraoral infusion via...

Read time: 2 min

Congress highlights

Psychotic depression – From biology to the clinic

Psychotic depression may develop in response to a major traumatic event; such as bereavement or...

Read time: 4 min

Early intervention in schizophrenia may improve long-term outcome

Schizophrenia may not be as disabling if identified and treated early, resulting in many benefits...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country